APA (7th ed.) Citation

Greenberg, P. D., Anderson, K. G., Oda, S. K., Bates, B. M., Burnett, M. G., Suarez, M. R., & Ruskin, S. L. Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Greenberg, Philip D., Kristin G. Anderson, Shannon K. Oda, Breanna M. Bates, Madison G. Burnett, Magdalia Rodgers Suarez, and Susan L. Ruskin. Engineering Adoptive T Cell Therapy to Co-opt Fas Ligand-mediated Death Signaling in Ovarian Cancer Enhances Therapeutic Efficacy. BMJ Publishing Group.

MLA (9th ed.) Citation

Greenberg, Philip D., et al. Engineering Adoptive T Cell Therapy to Co-opt Fas Ligand-mediated Death Signaling in Ovarian Cancer Enhances Therapeutic Efficacy. BMJ Publishing Group.